133 related articles for article (PubMed ID: 17482135)
1. Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening.
Khawaja XZ
Anal Biochem; 2007 Jul; 366(1):80-6. PubMed ID: 17482135
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo.
Mackay KB; Loddick SA; Naeve GS; Vana AM; Verge GM; Foster AC
J Cereb Blood Flow Metab; 2003 Oct; 23(10):1160-7. PubMed ID: 14526226
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein-4 and -5 by pregnancy-associated plasma protein-A.
Gyrup C; Oxvig C
Biochemistry; 2007 Feb; 46(7):1972-80. PubMed ID: 17249697
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein (IGFBP)-mediated hair cell survival on the mouse utricle exposed to neomycin: the roles of IGFBP-4 and IGFBP-5.
Park JY; Park YH; Shin DH; Oh SH
Acta Otolaryngol Suppl; 2007 Oct; (558):22-9. PubMed ID: 17882566
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients.
Choi YS; Kim SH; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY
Gynecol Obstet Invest; 2009; 67(2):73-80. PubMed ID: 18843190
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation.
Mukherjee S; Guidry C
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1892-9. PubMed ID: 17389525
[TBL] [Abstract][Full Text] [Related]
11. Enhanced insulin-like growth factor-I (IGF-I) cell association at reduced pH is dependent on IGF binding protein-3 (IGFBP-3) interaction.
Forsten-Williams K; Cassino TR; Delo LJ; Bellis AD; Robinson AS; Ryan TE
J Cell Physiol; 2007 Feb; 210(2):298-308. PubMed ID: 17044083
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
13. Expression, content, and localization of insulin-like growth factor I in human achilles tendon.
Olesen JL; Heinemeier KM; Langberg H; Magnusson SP; Kjaer M; Flyvbjerg A
Connect Tissue Res; 2006; 47(4):200-6. PubMed ID: 16987751
[TBL] [Abstract][Full Text] [Related]
14. Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects.
Malberg JE; Platt B; Rizzo SJ; Ring RH; Lucki I; Schechter LE; Rosenzweig-Lipson S
Neuropsychopharmacology; 2007 Nov; 32(11):2360-8. PubMed ID: 17342171
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Kawada M; Inoue H; Arakawa M; Ikeda D
Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
[TBL] [Abstract][Full Text] [Related]
16. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
17. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
18. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
19. Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors.
Delle Fratte S; Piubelli C; Domenici E
J Biomol Screen; 2002 Dec; 7(6):541-6. PubMed ID: 14599352
[TBL] [Abstract][Full Text] [Related]
20. Identification of a nonpeptide ligand that releases bioactive insulin-like growth factor-I from its binding protein complex.
Liu XJ; Xie Q; Zhu YF; Chen C; Ling N
J Biol Chem; 2001 Aug; 276(35):32419-22. PubMed ID: 11445558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
